Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

completed360%
not_yet_recruiting120%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Perimenstrual Symptoms and Emotional Dysregulation in Autism

NCT06871345
completednot_applicable

Initial Parenteral Nutrition Education of Parent Assessment Plan

NCT04816734
completed

Existential Distress in Patients with Advanced Cancer and Their Caregivers

NCT04600206
terminatedphase_2

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

NCT00112749
completed

Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders

NCT02450240

Clinical Trials (5)

Showing 5 of 5 trials
NCT06871345Not Applicable

Perimenstrual Symptoms and Emotional Dysregulation in Autism

Not Yet Recruiting
NCT04816734Not Applicable

Initial Parenteral Nutrition Education of Parent Assessment Plan

Completed
NCT04600206

Existential Distress in Patients with Advanced Cancer and Their Caregivers

Completed
NCT00112749Phase 2

Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer

Terminated
NCT02450240

Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5